National Bank of Canada FI Boosts Holdings in The Allstate Co. (NYSE:ALL)

National Bank of Canada FI lifted its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 38.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,159 shares of the insurance provider's stock after purchasing an additional 54,396 shares during the period. National Bank of Canada FI owned 0.07% of Allstate worth $37,625,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Apella Capital LLC boosted its position in shares of Allstate by 1.9% during the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider's stock worth $623,000 after purchasing an additional 60 shares in the last quarter. Intrust Bank NA boosted its holdings in Allstate by 0.5% in the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider's stock worth $2,340,000 after acquiring an additional 61 shares in the last quarter. Perigon Wealth Management LLC grew its stake in Allstate by 2.1% in the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider's stock valued at $571,000 after acquiring an additional 62 shares during the period. Mather Group LLC. increased its holdings in shares of Allstate by 1.7% during the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider's stock valued at $697,000 after acquiring an additional 62 shares in the last quarter. Finally, Angeles Wealth Management LLC raised its position in shares of Allstate by 4.6% during the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider's stock worth $270,000 after purchasing an additional 62 shares during the period. Institutional investors and hedge funds own 76.47% of the company's stock.

Remove Ads

Allstate Stock Performance

ALL traded down $18.58 during trading hours on Friday, hitting $186.74. The stock had a trading volume of 3,351,598 shares, compared to its average volume of 1,590,545. The stock has a market cap of $49.49 billion, a PE ratio of 10.99, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The Allstate Co. has a 1 year low of $156.66 and a 1 year high of $212.91. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The company's fifty day simple moving average is $197.37 and its 200 day simple moving average is $194.35.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. Equities analysts anticipate that The Allstate Co. will post 18.74 earnings per share for the current year.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were issued a dividend of $1.00 per share. This is a boost from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. This represents a $4.00 dividend on an annualized basis and a yield of 2.14%. Allstate's dividend payout ratio is 23.54%.

Allstate declared that its Board of Directors has approved a share buyback program on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to buy up to 3% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.

Analysts Set New Price Targets

Several analysts recently issued reports on ALL shares. Wells Fargo & Company lifted their price target on shares of Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research report on Tuesday, January 14th. Argus raised shares of Allstate from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. StockNews.com lowered shares of Allstate from a "buy" rating to a "hold" rating in a report on Monday, March 31st. Barclays decreased their price objective on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a report on Monday, January 6th. Finally, Keefe, Bruyette & Woods lifted their target price on Allstate from $235.00 to $240.00 and gave the company an "outperform" rating in a research report on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $219.80.

Insiders Place Their Bets

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This represents a 68.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.80% of the stock is owned by corporate insiders.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.